|
|
|
|
Highlights of Current Issue
 |
|
April-June 2023 | Vol 69 | Issue 2
|
|
|
|
|
| Editorial |
|
| Neuroendocrine neoplasm: Current understanding |
|
|
|
| AR Lila, SS Memon |
|
|
An article titled “Progress report: The carcinoid syndrome” by Grahame-Smith, published in 1970, starts with a quote by an English chemist John Mayow “As a rule, the disease can sc... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| |
| Editorial Commentary |
|
| Lessons learnt from therapeutic drug monitoring of levetiracetam |
|
|
|
| NN Rege |
|
|
Therapeutic drug concentration monitoring (TDM) plays a valuable role in guiding the management of patients with antiepileptic drugs. It is a valuable tool for clinicians to optimize drug regimens f... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| |
| Editorial Commentary |
|
| Littoral cell neoplasm: A least understood splenic tumour |
|
|
|
| K Ghosh |
|
|
I read with interest the report of a littoral cell angioma (LCA) of spleen detected after the patient was operated for renal cell carcinoma.[1] Splenic tumor may evolve from lymphoid tissues, blood ... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
Read more.... |
|
|
|
Table of Contents |
|
|
Click on image for details |
|
WHY PUBLISH WITH US
|
|
|
|
Indexed with most international bibliographic databases.
|
|
|
Online submission
|
|
|
Quick review
(average 28 days)
|
|
|
Free full text access
|
|
|
Immediate publication on acceptance
|
|
|
more...
|
|
